BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $359,596 | +43.8% | 14,952 | +83.1% | 0.01% | +28.6% |
Q1 2023 | $249,982 | +24.4% | 8,164 | +58.9% | 0.01% | +16.7% |
Q4 2022 | $200,986 | -81.0% | 5,139 | -76.9% | 0.01% | -83.8% |
Q3 2022 | $1,059,000 | -52.6% | 22,234 | -61.5% | 0.04% | -63.0% |
Q2 2022 | $2,233,000 | +80.2% | 57,677 | +166.7% | 0.10% | +72.4% |
Q1 2022 | $1,239,000 | +3.2% | 21,627 | +56.7% | 0.06% | -38.9% |
Q3 2021 | $1,201,000 | +42.6% | 13,803 | +110.9% | 0.10% | +33.8% |
Q2 2021 | $842,000 | -41.2% | 6,544 | -63.4% | 0.07% | -45.8% |
Q1 2021 | $1,431,000 | +102.1% | 17,878 | +106.2% | 0.13% | +74.7% |
Q4 2020 | $708,000 | – | 8,669 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |